Effect of glucagon‐like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and <scp>meta‐analysis</scp>-Reference-Cited by-同舟云学术

Effect of glucagon‐like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

Published:2022-06-06 Issue:9 Volume:24 Page:1869-1881
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Yuan Daniel¹²^ORCID,Sharma Harman²^ORCID,Krishnan Anirudh²,Vangaveti Venkat N.¹²^ORCID,Malabu Usman H.¹²³^ORCID

Affiliation:

1. Translational Research in Endocrinology and Diabetes (TREAD), College of Medicine and Dentistry James Cook University Douglas Queensland Australia

2. College of Medicine and Dentistry James Cook University Douglas Queensland Australia

3. Townsville University Hospital Douglas Queensland Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14776

Reference48 articles.

1. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies

2. GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists

3. Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

4. The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes

5. GLP-1 Receptor Agonists and Kidney Protection

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors;Diabetes, Obesity and Metabolism;2024-07

2. The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study;Endocrine Practice;2024-07

3. Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile;Expert Opinion on Drug Safety;2024-05-13

4. Is Tirzepatide the New Game Changer in Type 2 Diabetes?;Endocrines;2024-02-01

5. Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk;Journal of Clinical Medicine;2024-01-29